Inflammatory Bowel Disease in Children: Psychological and Psychiatric Issues

The overlap between inflammatory bowel disease (IBD) and psychiatric disorders has been studied extensively. We reviewed the limited literature targeting the complex relationship between IBD and psychiatric disorders in children and adolescents. Findings from this review were compared with findings...

Full description

Saved in:
Bibliographic Details
Published in:Current psychiatry reports 2010-06, Vol.12 (3), p.222-228
Main Authors: Deshmukh, Parikshit, Kulkarni, Gaurav, Lackamp, Jeanne
Format: Article
Language:English
Subjects:
Adolescent
Child
Child & adolescent psychiatry
Female
Humans
Inflammatory bowel disease
Inflammatory Bowel Diseases - epidemiology
Inflammatory Bowel Diseases - psychology
Male
Medicine
Medicine & Public Health
Mental disorders
Mental Disorders - diagnosis
Mental Disorders - epidemiology
Mental Disorders - therapy
Pediatrics
Prevalence
Psychiatry
Psychotherapy
Teenagers
United States - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The overlap between inflammatory bowel disease (IBD) and psychiatric disorders has been studied extensively. We reviewed the limited literature targeting the complex relationship between IBD and psychiatric disorders in children and adolescents. Findings from this review were compared with findings from available studies in adults. Results reflecting an association between IBD and psychiatric illnesses were observed in children and adolescents and were consistent with results in adults. In adults with IBD, many studies have reflected the advantages of psychotherapeutic treatment, including faster recovery, improved quality of life, and reduced health care use. Unfortunately, such studies are scarce in the child and adolescent population. Psychopharmacologic studies also are limited in adult and pediatric populations. At this time, the literature on treatment of the pediatric IBD population remains minimal, and the need to study screening and treatment modalities is critical.
ISSN:1523-3812
1535-1645
DOI:10.1007/s11920-010-0111-0